A Single-Blind Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and beta-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes).

Trial Profile

A Single-Blind Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and beta-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes).

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2012

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Glucose intolerance
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Dec 2011 Actual patient number (21) and actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 16 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Sep 2010 Planned end date changed from 1 Jul 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top